Lincoln Park Capital Fund logo

Lincoln Park Capital Fund

North America, Illinois, United States, Chicago

Description

Lincoln Park Capital Fund is a Chicago-based asset management firm focused on opportunistic investing in public and private companies.

Investor Profile

Lincoln Park Capital Fund has made 32 investments, with 1 in the past 12 months and 69% as lead.

Stage Focus

  • Post Ipo Equity (91%)
  • Seed (3%)
  • Private Equity (3%)
  • Post Ipo Secondary (3%)

Country Focus

  • United States (88%)
  • Canada (9%)
  • Denmark (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Biopharma
  • Oncology
  • Life Science
  • Wellness
  • Cleantech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lincoln Park Capital Fund frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Altium Capital
North America, New York, United States, New York
Co-Investments: 2
DC
North America, Illinois, United States, Chicago
Co-Investments: 1
Sio Capital Management
North America, New York, United States, New York
Co-Investments: 2
Monashee Investment Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 1
MATH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
Ikarian Capital
North America, Texas, United States, Dallas
Co-Investments: 1
M25
North America, Illinois, United States, Chicago
Co-Investments: 1

Which angels does Lincoln Park Capital Fund often collaborate with?

PM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Lincoln Park Capital Fund?

Dare Bioscience

La Jolla, California, United States

Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityOct 21, 2024
Amount Raised: $15,000,000
Meta Materials

Dartmouth, Nova Scotia, Canada

Meta Materials is a platform technology company that partners with OEMs across an expanding range of industries.

Advanced MaterialsArtificial Intelligence (AI)CleanTechInformation TechnologyNanotechnology
Post Ipo EquitySep 11, 2023
Amount Raised: $50,000,000
Cybin

Toronto, Ontario, Canada

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BiotechnologyHealth CareMental HealthPharmaceutical
Post Ipo EquityMay 30, 2023
Amount Raised: $30,146,837
Eterna Therapeutics

Cambridge, Massachusetts, United States

Eterna Therapeutics is a biopharmaceutical firm in the clinical stages that researches and develops innovative cytokine-based therapies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityApr 11, 2023
Amount Raised: $10,000,000
Marker Therapeutics

Minneapolis, Minnesota, United States

Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.

BiotechnologyTherapeutics
Post Ipo EquityDec 13, 2022
Amount Raised: $25,000,000
PaxMedica

Tarrytown, New York, United States

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityNov 17, 2022
Amount Raised: $20,000,000
Kintara Therapeutics

Vancouver, British Columbia, Canada

Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 3, 2022
Amount Raised: $20,000,000
Evaxion Biotech

Copenhagen, Hovedstaden, Denmark

Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.

Biotechnology
Post Ipo EquityJun 7, 2022
Amount Raised: $40,000,000
Aquestive Therapeutics

Warren, New Jersey, United States

Aquestive is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems.

Pharmaceutical
Post Ipo EquityApr 13, 2022
Amount Raised: $40,000,000
Biodesix

Broomfield, Colorado, United States

Biodesix is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services.

BiotechnologyHealth CareHealth DiagnosticsMedical
Post Ipo EquityMar 7, 2022
Amount Raised: $50,000,000